ClearPoint Neuro (CLPT) Non Operating Interest Expenses (2011 - 2026)

ClearPoint Neuro has disclosed Non Operating Interest Expenses across 13 years of filings, most recently posting $1.4 million for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses rose 287.12% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $3.2 million (up 465.48% YoY), while the FY2025 annual figure was $2.4 million, up 363.32% from the prior year.
• Non Operating Interest Expenses came in at $1.4 million for Q2 2026 at ClearPoint Neuro, up from $1.4 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $1.4 million in Q2 2026 to a low of $91000.0 in Q2 2022.
• Average Non Operating Interest Expenses over 3 years is $675000.0, with a median of $365000.0 recorded in 2025.
• Year-over-year, Non Operating Interest Expenses sank 68.07% in 2022 and surged 287.12% in 2026.
• Over 3 years, Non Operating Interest Expenses stood at $91000.0 in 2022, then surged by 301.1% to $365000.0 in 2025, then surged by 287.12% to $1.4 million in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $1.4 million in Q2 2026, $1.4 million in Q1 2026, and $365000.0 in Q2 2025.